Deutsche Bank (ETR:DBKGn) initiated coverage on Xenon Pharmaceuticals (NASDAQ:XENE) with a Buy rating and a price target of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results